杂志简称：asian pac j allergy
中文译名：《亚太过敏与免疫学杂志》
收录属性：scie（2024版）, 英文期刊,
自引率：1.20%
投稿方向：医学、allergy 过敏、immunology 免疫学
SCI/E期刊基本信息
出版周期：季刊 地区：泰国
中科院分区：4区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN0125-877X；E-ISSN2228-8694
杂志语言：英语
出版国家：泰国
杂志官网 联系方式
出版地址：ALLERGY IMMUNOL SOC THAILAND,,MAHIDOL UNIV,DEPT MICROBIOL IMMUNOL,FACULTY TROPICAL MED,BANGKOK,THAILAND,10400
杂志邮箱：
投稿网址：https://apjai.msubmit.net/cgi-bin/main.plex
杂志官方网址：https://apjai-journal.org/
出版商网址：
杂志投稿要求
投稿须知【杂志社官方网站信息】
Author guidelines for APJAI
(effective as of Aug6, 2021)
Please submit your manuscript via online submission system at the following address: http://www.apjai-journal.org.
Mission Statement
The Asian Pacific Journal of Allergy and Immunology (APJAI) publishes original research articles, clinical observations, case reports and reviews on various aspects of allergy and immunology provided that they have not been, and will not be, published elsewhere in whole, or in part, without the Editor’s permission. Papers accepted become the copyright of the Journal. Authors are responsible for all statements in articles submitted to the APJAI.
Journal Publication Policies and Procedures
The APJAI will consider for publication those papers directly related to allergy and immunology and has agreed to follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (the “Uniform Requirements”) of the International Committee of Medical Journal Editors (ICMJE), the full text of which is available at http://www.icmje.org. The manuscript submission instructions for the APJAI submission are consistent with the 2009 version of the Uniform Requirements. The Editor assumes that upon submission of a manuscript, all listed authors have agreed with the APJAI policies. Manuscripts that do not meet these guidelines will be returned to the submitting author for revision prior to any further consideration for peer review.
Submissions will be considered for publication in APJAI only if they are submitted solely to APJAI. It must not have been previously published and must not be under consideration for publication elsewhere. All published manuscripts become the permanent property of the APJAI and may not be published elsewhere without written permission.
Ethical Approval of Studies and Informed Consent
For all research studies involving human subjects or research material derived from humans, a statement describing approval by the appropriate Institutional Review Board (IRB) is required in the Methods Section. Authors must declare how and if the informed consents were obtained from the study participants, if the study is conducted in humans, in the Methods Section. Studies exempted from IRB approval by their respective boards should be indicated in the Methods Section. Institutional Review Board approval and informed consent statements are not required for Case Reports. Studies involving experimental animals must include a statement in the Methods Section indicating that institutional or national guidelines were followed for the care and use of the animals. Failure to comply with this requirement will result in the manuscript being returned without review.
Clinical Trial Registration
APJAI requires investigators to preregister their clinical trials in a public trial registry approved by WHO (http://www.who.int/ictrp/network/primary/en/).
APJAI has adopted the WHO’s definition of a clinical trial: “any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.” The clinical trial registration number and name of the registry should be clearly identified on the title page and in the Methods Section.
Manuscript Preparation and Submission Requirements
The authors must submit the cover letter, title page, abstract, manuscript text, tables, figures, and/or supplement files. Please read the instruction in the online submission system carefully as many changes have been implemented. All manuscripts are subjected to open peer-review.